Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphoglycerate kinase 1 pseudogene is a **nonfunctional genomic sequence** that closely resembles the protein-coding phosphoglycerate kinase 1 (PGK1) gene but does not encode a protein product[3][4]. Pseudogenes such as this arise by duplication or retrotransposition of functional genes and accumulate mutations that prevent their expression or the production of a functional protein[5]. Unlike the canonical PGK1 gene, which is a key glycolytic enzyme involved in cellular energy metabolism, the pseudogene has no known biological, enzymatic, or disease-related function[3][7]. As a result, it is not considered a therapeutic target, does not interact with drugs, and is not associated with human disease. This entry refers to a **pseudogene**, not to the canonical or druggable **phosphoglycerate kinase 1 (PGK1)** enzyme, which has clinical and biological significance[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate kinase 1 pseudogene.